Overview of applications amp indications 2012 Haemonetics Corp COLCOPY000481AA Allogeneic Transfusions Potential Risks Quality of Stored blood ID: 774741
Download Presentation The PPT/PDF document " Benefits of autotransfusion" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Benefits of autotransfusion
Overview of applications & indications
© 2012 Haemonetics Corp COL-COPY-000481(AA)
Slide2Allogeneic Transfusions - Potential RisksQuality of Stored bloodWashed versus unwashed bloodHematocrit of different Blood ProductsApplications for AutotransfusionIndications for AutotransfusionContraindications for AutotransfusionIntraoperative Autotransfusion - Benefits
Content
Slide3Viral infectionBacterial infectionTransfusion reactionsImmune suppression
Allogeneic
Transfusions - Potential Risks
Slide4Quality of Stored blood
Source: Tsai et al. Transfusion 2004;44:1626-34
Slide5Relative risk of exposure to allogeneic RBC Washed: 54% transfused Unwashed: 73% transfusedWashed RBCs are high quality (measured by post-transfusion survival)Unwashed bloodLower HctPlatelets present, but function may be impairedAnticoagulant present in measurable amountsCoagulation components could cause coagulation abnormalities
Washed versus unwashed blood
Source: The Cochrane Library 2006, Issue 1
Slide6Hematocrit of Different Blood Products
Unwashed
Autotransfusion~30% Hematocrit
BankedBlood50%–60% Hematocrit
OrthoPAT
Blood Product
Up to 70% Hematocrit
Slide7Widely applied technology
Used for high blood loss surgeries aortic aneurismUsed for elective surgeries with medium blood loss orthopedic surgeriescardiac surgeriesObstetric surgeries caesarean section with high risk factors for hemorrhage – amniotic fluid needs to be removed and leucodepletion filter use is recommendedAcceptable by patients with specific religious beliefs
Applications for Autotransfusion
Slide8Anticipated blood loss (adult) ≥ 20% of estimated blood volumeAnticipated blood loss (child) ≥ 15% of estimated blood volumeUndergoing procedure for which blood is routinely cross-matchedProcedure for which more than 20% of patients are transfused
Indications for Autotransfusion
Slide9Mean transfusion volume exceeds one unitThe patient has alloantibodiesThe patient has a low hematocrit and/or no predeposit units of bloodCompatible allogeneic blood is not available.
Indications for Autotransfusion (cont.)
Slide10Physician must
determine risk/benefit factorAutotransfusion with cancer surgery is normally contraindicatedContamination of the surgical site e.g. abdominal procedure pose the risk of contamination of shed bloodPresence of amniotic fluid is a potential contamination: removal of amniotic fluid and use of leucodepletion filter are recommendedEvery decision is under the responsibility of thephysician(s) treating the patient.
Contraindications for Autotransfusion
Slide11Reduces need for allogeneic blood by 40-60%Prevents transfusion-transmitted diseasePrevents red cell alloimmunizationHigher O2 delivery capacityWashed RBC reduces exposure to activated clotting factors, biologic modifiers, surgical debrisImproved tissue perfusion
Intraoperative Autotransfusion - Benefits
Source: Yomtovian R. In Transfusion Reactions 2001, Tsai A. Transfusion 2004;44:1626
Slide12Autotransfusion & Length of Stay (LOS)
Scott et al.Cardiac surgery, CABGN=1746Prospective, randomized, controlled trialAllogeneic transfusion vs. not transfusedReduced LOS by 2.9 days Transfused Not transfused 7.2 days 4.3 days p 0.001
Intraoperative Autotransfusion – Benefits (cont.)
Source: Scott et al. American Society of Anesthesiologists Abstract 2006
Slide13Autotransfusion & Length of Stay (LOS)Innerhofer et al.Prospective, observational studyN=385Elective orthopedic surgery (primary/revision hip replacement, spinal surgery)Recipients of autologous blood: 0.8 day less LOS
Source: Innerhofer et al. Transfusion 1999;39:625-632
Intraoperative Autotransfusion – Benefits (cont.)
Slide14Intraoperative Autotransfusion – Benefits (cont.)
Clark et alN = 398; 5 hip or knee cohortsOrthoPAT used, without preoperative autologous blood donation
Source: J Arthroplasty 2006;21:23-35
OrthoPAT® System reduced the need for allogeneictransfusions
Procedure
Allogeneic
Transfusion Risk Reduction
P
Primary/revision hip
2.7-fold
.05
Primary/revision Knee
2.3-fold
.05
Slide15Thank
you
for
your
attention